
November 2004 - Part 2
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves Sacituzumab Govitecan-hziy for First-Line Metastatic Triple-Negative Breast Cancer
2
CDC Officially Ends Hantavirus Response as Outbreak Risk Recedes
3
Treatment Burden, End-of-Life Symptom Gaps in Multiple Myeloma
4
ATTR-CM Incidence, Prevalence Rose Sharply in the US
5